image
Molecular Partners AG MOLN
Healthcare - Biotechnology - NASDAQ - CH
Watchlist
$ 3.79
-1.45 %
$ 140 M
Market Cap
-2.12
P/E
BALANCE SHEET
159 M ASSETS
-20.08%
Growth Rates
1Year -20.08%
3Years -2.81%
5Years 8.60%
7Years 1.34%
10Years -2.00%
16.9 M LIABILITIES
-22.95%
Growth Rates
1Year -22.95%
3Years -36.31%
5Years -19.76%
7Years -6.82%
10Years -9.44%
142 M EQUITY
-19.72%
Growth Rates
1Year -19.72%
3Years 9.70%
5Years 21.21%
7Years 2.80%
10Years -0.47%
BALANCE SHEET DECOMPOSITION
Balance Sheet Molecular Partners AG
image
Current Assets 154 M
Cash & Short-Term Investments 149 M
Receivables 2.59 M
Other Current Assets 2.25 M
Non-Current Assets 4.25 M
Long-Term Investments 0
PP&E 4.2 M
Other Non-Current Assets 49 K
94.27 %Total Assets$158.5m
Current Liabilities 10.8 M
Accounts Payable 679 K
Short-Term Debt 1.22 M
Other Current Liabilities 8.89 M
Non-Current Liabilities 6.11 M
Long-Term Debt 1.23 M
Other Non-Current Liabilities 4.88 M
4.02 %7.21 %52.63 %7.26 %28.89 %Total Liabilities$16.9m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 63.9 67.3 87.9 71.8 133.7 75.7 99.0 131.3 149.7 195.4 188.4 96.1
Short Term Investments 85.6 119.6 161.2 61.0 40.0 19.4 0 9.7 30.5 20.0 0 0
Receivables 2.6 1.7 1.7 25.7 2.8 2.5 51.6 1.2 0.8 1.3 2.9 11.5
Inventory 0 0 0 2 (0.2) (0.5) (2.3) (9.4) 1 0.1 0.4 0
Other Current Assets 2.2 2.5 3.9 5.7 1.3 2.3 2.7 0.3 0.5 0.1 0.7 0.1
Total Current Assets 154.3 192.5 254.8 164.2 177.8 99.9 153.3 142.5 181.6 216.9 192.0 107.8
PP&E 4.2 5.7 7.2 8.1 9.4 4.2 1.5 1.9 2.5 2.5 2.0 2.3
Intangible Assets 49 K 0.2 0.3 0.3 0.3 0.8 0.4 27 K 47 K 17.5 K 27.3 K 22.6 K
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 (7.5) 1 K (9.7) (5.0) 0 0 0 0 0 1
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 158.5 198.4 262.3 172.7 187.5 104.9 155.2 144.4 184.1 219.4 194.0 110.1
LIABILITIES
Accounts Payable 0.7 0.4 1.0 4.9 2.8 2.0 2.1 0.7 1.0 1.2 0.3 0.2
Short Term Debt 1.2 1.2 1.2 1.2 1.2 1.3 0 0 0 0 0 0
Other Current Liabilities 8.9 8.5 8.6 11.6 9.4 7.0 6.9 4.5 4.3 25.2 3.2 4.0
Total Current Liabilities 10.8 14.4 17.3 46.9 57.7 28.6 36.9 14.1 15.8 26.4 22.1 22.7
Long Term Debt 1.2 2.4 3.7 4.8 6.0 1.3 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 4.9 5.1 2.6 6.7 13.7 10.9 5.7 4.0 5.7 41.2 3.1 1.7
Total Liabilities 16.9 21.9 27.1 65.4 80.3 50.8 63.5 27.7 48.3 67.6 45.5 61.8
EQUITY
Common Stock 4.0 3.6 3.6 3.2 2.9 2.2 2.1 2.1 2.1 2.0 2.0 1.5
Retained Earnings (246.3) (191.8) (127.8) (250.9) (195.2) (130.9) (89.9) (60.7) (37.3) (18.0) (17.3) (14.1)
Other Accumulative Comprehensive Income/Loss 0 0 (1.0) 0 0 0 (6.9) (6.1) (5.1) (4.1) (3.3) (2.5)
Total Equity 141.6 176.4 235.2 107.3 107.2 54.1 91.7 116.7 135.8 151.8 148.5 48.3
Total Liabilities and Equity 158.5 198.4 262.3 172.7 187.5 104.9 155.2 144.4 184.1 219.4 194.0 110.1
SHARES OUTSTANDING
Common Shares Outstanding 34.0 32.8 32.5 31.0 25.0 21.4 21.2 20.9 20.4 19.5 15.2 19.5